| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myocardium | 34 | 2016 | 1204 | 1.900 |
Why?
|
| Gene Transfer Techniques | 21 | 2017 | 173 | 1.850 |
Why?
|
| Heart Failure | 31 | 2021 | 1180 | 1.690 |
Why?
|
| Heart | 19 | 2021 | 850 | 1.680 |
Why?
|
| Myocytes, Cardiac | 25 | 2014 | 442 | 1.520 |
Why?
|
| Cofilin 2 | 2 | 2020 | 2 | 1.250 |
Why?
|
| Calcium-Transporting ATPases | 15 | 2006 | 40 | 1.190 |
Why?
|
| Genetic Therapy | 21 | 2010 | 291 | 1.180 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 19 | 2010 | 23 | 1.170 |
Why?
|
| Calcium | 28 | 2010 | 929 | 1.160 |
Why?
|
| Myocardial Contraction | 33 | 2013 | 383 | 1.150 |
Why?
|
| Cardiomyopathy, Dilated | 7 | 2015 | 106 | 1.070 |
Why?
|
| Cardiomyopathies | 6 | 2021 | 167 | 1.010 |
Why?
|
| Alzheimer Disease | 3 | 2020 | 565 | 1.010 |
Why?
|
| Amyloid | 4 | 2020 | 39 | 1.000 |
Why?
|
| Protein Folding | 4 | 2021 | 82 | 0.910 |
Why?
|
| Amyloid beta-Peptides | 4 | 2020 | 191 | 0.890 |
Why?
|
| Calcium-Binding Proteins | 11 | 2010 | 114 | 0.790 |
Why?
|
| Cardiac Output, Low | 5 | 2004 | 52 | 0.780 |
Why?
|
| Ventricular Dysfunction, Left | 3 | 2020 | 277 | 0.730 |
Why?
|
| Genetic Vectors | 17 | 2017 | 312 | 0.730 |
Why?
|
| Myocardial Reperfusion Injury | 5 | 2010 | 84 | 0.640 |
Why?
|
| Animals | 75 | 2021 | 20881 | 0.630 |
Why?
|
| Adenoviridae | 18 | 2010 | 295 | 0.560 |
Why?
|
| Gene Expression Regulation | 6 | 2015 | 1293 | 0.560 |
Why?
|
| Brain | 4 | 2020 | 2176 | 0.540 |
Why?
|
| Tachycardia, Ventricular | 4 | 2012 | 153 | 0.540 |
Why?
|
| Cardiomegaly | 8 | 2006 | 213 | 0.490 |
Why?
|
| Protein Aggregation, Pathological | 3 | 2021 | 13 | 0.450 |
Why?
|
| Protein Processing, Post-Translational | 3 | 2014 | 284 | 0.450 |
Why?
|
| Rats | 32 | 2017 | 5300 | 0.450 |
Why?
|
| Humans | 70 | 2021 | 68618 | 0.400 |
Why?
|
| Myocardial Infarction | 10 | 2011 | 807 | 0.380 |
Why?
|
| Receptors, Adrenergic, beta | 11 | 2005 | 153 | 0.370 |
Why?
|
| Ventricular Fibrillation | 2 | 2008 | 85 | 0.360 |
Why?
|
| Presenilin-1 | 1 | 2010 | 28 | 0.350 |
Why?
|
| Gene Expression | 11 | 2013 | 770 | 0.350 |
Why?
|
| Sarcoplasmic Reticulum | 11 | 2013 | 40 | 0.340 |
Why?
|
| Phosphorylation | 7 | 2020 | 1200 | 0.330 |
Why?
|
| Proteins | 2 | 2010 | 474 | 0.320 |
Why?
|
| Action Potentials | 6 | 2014 | 223 | 0.290 |
Why?
|
| Ventricular Remodeling | 5 | 2012 | 318 | 0.290 |
Why?
|
| DNA, Antisense | 2 | 2008 | 9 | 0.290 |
Why?
|
| Gene Expression Profiling | 5 | 2013 | 498 | 0.270 |
Why?
|
| Gene Targeting | 3 | 2003 | 58 | 0.270 |
Why?
|
| Male | 44 | 2019 | 37321 | 0.270 |
Why?
|
| Gene Transfer, Horizontal | 3 | 2005 | 3 | 0.270 |
Why?
|
| Aorta | 5 | 2017 | 316 | 0.260 |
Why?
|
| Transcription, Genetic | 4 | 2013 | 562 | 0.260 |
Why?
|
| Cells, Cultured | 18 | 2013 | 2673 | 0.240 |
Why?
|
| Muscle Proteins | 4 | 2013 | 94 | 0.240 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 2 | 2014 | 13 | 0.230 |
Why?
|
| Calcium Signaling | 3 | 2014 | 97 | 0.230 |
Why?
|
| Disease Models, Animal | 14 | 2012 | 2550 | 0.230 |
Why?
|
| Immunohistochemistry | 4 | 2016 | 1174 | 0.230 |
Why?
|
| Signal Transduction | 11 | 2019 | 2689 | 0.230 |
Why?
|
| Female | 27 | 2019 | 38074 | 0.220 |
Why?
|
| Rats, Sprague-Dawley | 14 | 2010 | 2083 | 0.210 |
Why?
|
| Cardiovascular Diseases | 2 | 2021 | 940 | 0.210 |
Why?
|
| Endoplasmic Reticulum | 3 | 2008 | 148 | 0.210 |
Why?
|
| Isoproterenol | 12 | 2010 | 163 | 0.200 |
Why?
|
| Actin Cytoskeleton | 2 | 2020 | 37 | 0.200 |
Why?
|
| In Vitro Techniques | 10 | 2002 | 765 | 0.200 |
Why?
|
| Proteostasis | 1 | 2021 | 3 | 0.190 |
Why?
|
| Proteostasis Deficiencies | 1 | 2021 | 2 | 0.190 |
Why?
|
| Muscle Development | 2 | 2012 | 31 | 0.190 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2013 | 627 | 0.190 |
Why?
|
| Adult Stem Cells | 2 | 2011 | 13 | 0.190 |
Why?
|
| Aged | 14 | 2016 | 14862 | 0.190 |
Why?
|
| Mice | 15 | 2015 | 8474 | 0.180 |
Why?
|
| Actin Depolymerizing Factors | 1 | 2020 | 16 | 0.180 |
Why?
|
| Guinea Pigs | 10 | 2002 | 124 | 0.180 |
Why?
|
| Injections | 3 | 2017 | 119 | 0.180 |
Why?
|
| Aging | 6 | 2016 | 911 | 0.180 |
Why?
|
| Heart Ventricles | 11 | 2013 | 738 | 0.170 |
Why?
|
| Carrier Proteins | 5 | 2013 | 597 | 0.170 |
Why?
|
| Heart Atria | 4 | 2013 | 206 | 0.170 |
Why?
|
| Dementia | 1 | 2021 | 158 | 0.170 |
Why?
|
| Actins | 1 | 2020 | 249 | 0.170 |
Why?
|
| Oxidative Stress | 2 | 2020 | 718 | 0.160 |
Why?
|
| Mitral Valve Prolapse | 1 | 2019 | 40 | 0.160 |
Why?
|
| Immunoblotting | 2 | 2016 | 254 | 0.160 |
Why?
|
| Plaque, Amyloid | 1 | 2019 | 31 | 0.160 |
Why?
|
| Apoptosis | 8 | 2010 | 1641 | 0.160 |
Why?
|
| Hypertrophy, Left Ventricular | 3 | 2008 | 140 | 0.160 |
Why?
|
| Cilia | 1 | 2019 | 94 | 0.160 |
Why?
|
| Amyloidosis | 2 | 2021 | 48 | 0.160 |
Why?
|
| Cardiovascular System | 1 | 2019 | 85 | 0.150 |
Why?
|
| Cell Differentiation | 4 | 2011 | 1034 | 0.150 |
Why?
|
| Mice, Knockout | 4 | 2019 | 1692 | 0.150 |
Why?
|
| Protein Kinases | 3 | 2004 | 122 | 0.150 |
Why?
|
| Endothelial Cells | 3 | 2012 | 384 | 0.150 |
Why?
|
| Mitral Valve Insufficiency | 2 | 2008 | 99 | 0.150 |
Why?
|
| MicroRNAs | 2 | 2013 | 447 | 0.140 |
Why?
|
| Atrial Natriuretic Factor | 3 | 2013 | 54 | 0.140 |
Why?
|
| Middle Aged | 18 | 2015 | 21147 | 0.140 |
Why?
|
| Veins | 1 | 2017 | 68 | 0.140 |
Why?
|
| Enzyme Activation | 5 | 2010 | 791 | 0.140 |
Why?
|
| Protein Aggregates | 1 | 2016 | 11 | 0.140 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2016 | 127 | 0.140 |
Why?
|
| Adult | 16 | 2015 | 21403 | 0.140 |
Why?
|
| Atrial Fibrillation | 3 | 2021 | 249 | 0.140 |
Why?
|
| Stroke Volume | 6 | 2021 | 586 | 0.140 |
Why?
|
| Regeneration | 4 | 2012 | 105 | 0.140 |
Why?
|
| Protein Multimerization | 1 | 2016 | 71 | 0.130 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2016 | 115 | 0.130 |
Why?
|
| Bone Density | 2 | 2007 | 159 | 0.130 |
Why?
|
| Polymorphism, Genetic | 2 | 2007 | 301 | 0.130 |
Why?
|
| Time Factors | 11 | 2019 | 4655 | 0.130 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 507 | 0.130 |
Why?
|
| Anesthesia | 1 | 2017 | 120 | 0.130 |
Why?
|
| Frozen Sections | 1 | 2015 | 14 | 0.130 |
Why?
|
| beta-Galactosidase | 5 | 2007 | 88 | 0.130 |
Why?
|
| Sampling Studies | 1 | 2015 | 80 | 0.130 |
Why?
|
| Genes, Viral | 2 | 2005 | 44 | 0.120 |
Why?
|
| Ventricular Function, Left | 6 | 2021 | 481 | 0.120 |
Why?
|
| Pulmonary Artery | 1 | 2017 | 323 | 0.120 |
Why?
|
| Sodium-Calcium Exchanger | 3 | 2003 | 69 | 0.120 |
Why?
|
| Isoenzymes | 4 | 2008 | 308 | 0.120 |
Why?
|
| Genes, Reporter | 3 | 2004 | 191 | 0.120 |
Why?
|
| Immunoglobulin Light Chains | 1 | 2013 | 19 | 0.110 |
Why?
|
| Receptors, Adrenergic, alpha | 1 | 1993 | 40 | 0.110 |
Why?
|
| Swine | 4 | 2008 | 672 | 0.110 |
Why?
|
| Cytological Techniques | 1 | 2013 | 23 | 0.110 |
Why?
|
| Phosphoprotein Phosphatases | 2 | 2005 | 67 | 0.110 |
Why?
|
| Calcineurin | 3 | 2004 | 13 | 0.110 |
Why?
|
| Heart Transplantation | 2 | 2015 | 328 | 0.110 |
Why?
|
| Endothelins | 1 | 1993 | 57 | 0.110 |
Why?
|
| Mice, Transgenic | 7 | 2012 | 1033 | 0.110 |
Why?
|
| Aged, 80 and over | 4 | 2016 | 4848 | 0.110 |
Why?
|
| Genetic Variation | 1 | 2013 | 220 | 0.110 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2005 | 411 | 0.100 |
Why?
|
| Myocardial Ischemia | 3 | 2002 | 172 | 0.100 |
Why?
|
| Immediate-Early Proteins | 1 | 2012 | 63 | 0.100 |
Why?
|
| RNA Interference | 1 | 2013 | 266 | 0.100 |
Why?
|
| Echocardiography | 2 | 2008 | 515 | 0.100 |
Why?
|
| Proteomics | 1 | 2014 | 246 | 0.100 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2012 | 34 | 0.100 |
Why?
|
| Glycoproteins | 1 | 2013 | 238 | 0.100 |
Why?
|
| Sex Characteristics | 3 | 2010 | 295 | 0.100 |
Why?
|
| Phosphatidylinositol 3-Kinases | 3 | 2012 | 223 | 0.100 |
Why?
|
| Down-Regulation | 4 | 2010 | 447 | 0.100 |
Why?
|
| Ephrin-A2 | 1 | 2011 | 1 | 0.100 |
Why?
|
| Ephrin-A1 | 1 | 2011 | 3 | 0.100 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2010 | 134 | 0.100 |
Why?
|
| Nuclear Matrix-Associated Proteins | 1 | 2010 | 2 | 0.100 |
Why?
|
| Hypertrophy | 2 | 2008 | 89 | 0.090 |
Why?
|
| Neovascularization, Pathologic | 1 | 2012 | 183 | 0.090 |
Why?
|
| Stem Cell Transplantation | 1 | 2011 | 58 | 0.090 |
Why?
|
| Ventricular Function | 2 | 2005 | 93 | 0.090 |
Why?
|
| Cardiomyopathy, Hypertrophic, Familial | 1 | 2010 | 8 | 0.090 |
Why?
|
| Sensitivity and Specificity | 1 | 2015 | 1753 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 2010 | 15 | 0.090 |
Why?
|
| Heart Function Tests | 1 | 2010 | 33 | 0.090 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 4 | 2008 | 216 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2013 | 710 | 0.090 |
Why?
|
| Cell Proliferation | 3 | 2010 | 1174 | 0.090 |
Why?
|
| Presenilin-2 | 1 | 2010 | 6 | 0.090 |
Why?
|
| Cross-Sectional Studies | 1 | 2016 | 2279 | 0.090 |
Why?
|
| Heat-Shock Proteins | 3 | 2021 | 69 | 0.090 |
Why?
|
| Adrenergic beta-Agonists | 4 | 2002 | 92 | 0.090 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2008 | 320 | 0.090 |
Why?
|
| Cellular Senescence | 1 | 2010 | 112 | 0.090 |
Why?
|
| Necrosis | 2 | 2008 | 239 | 0.090 |
Why?
|
| DNA, Mitochondrial | 1 | 2010 | 84 | 0.090 |
Why?
|
| Transduction, Genetic | 2 | 2007 | 81 | 0.090 |
Why?
|
| Hemodynamics | 4 | 2010 | 705 | 0.080 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2011 | 268 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2001 | 250 | 0.080 |
Why?
|
| DNA Replication | 1 | 2010 | 167 | 0.080 |
Why?
|
| Mitochondria | 2 | 2013 | 643 | 0.080 |
Why?
|
| Fibroblasts | 2 | 2012 | 902 | 0.080 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2019 | 214 | 0.080 |
Why?
|
| Cell Compartmentation | 1 | 2008 | 41 | 0.080 |
Why?
|
| Molecular Chaperones | 2 | 2008 | 81 | 0.080 |
Why?
|
| Alcohol-Induced Disorders | 1 | 2008 | 5 | 0.080 |
Why?
|
| Echocardiography, Doppler | 1 | 2008 | 87 | 0.080 |
Why?
|
| Transgenes | 2 | 2004 | 92 | 0.070 |
Why?
|
| Transcription Factors | 5 | 2012 | 753 | 0.070 |
Why?
|
| Potassium Channels | 2 | 1999 | 55 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 5 | 2013 | 2791 | 0.070 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2006 | 1085 | 0.070 |
Why?
|
| Dependovirus | 1 | 2007 | 34 | 0.070 |
Why?
|
| Hypertension | 2 | 2013 | 1535 | 0.070 |
Why?
|
| Glycogen Synthase Kinase 3 | 2 | 2004 | 64 | 0.070 |
Why?
|
| Mitral Valve | 1 | 2008 | 166 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2010 | 786 | 0.070 |
Why?
|
| Electrocardiography | 2 | 2012 | 601 | 0.070 |
Why?
|
| Receptors, Calcitriol | 1 | 2006 | 49 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 6 | 2007 | 1745 | 0.070 |
Why?
|
| Exons | 1 | 2006 | 122 | 0.070 |
Why?
|
| Estrogen Receptor alpha | 1 | 2007 | 65 | 0.070 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 3 | 2005 | 107 | 0.070 |
Why?
|
| Rats, Inbred Strains | 2 | 2006 | 532 | 0.070 |
Why?
|
| Mutation | 2 | 2010 | 1213 | 0.070 |
Why?
|
| Homeostasis | 2 | 2005 | 291 | 0.070 |
Why?
|
| Muscle Contraction | 3 | 2002 | 210 | 0.070 |
Why?
|
| Cell Adhesion Molecules | 1 | 2007 | 199 | 0.070 |
Why?
|
| Erythropoietin | 1 | 2006 | 96 | 0.070 |
Why?
|
| Coronary Circulation | 1 | 2006 | 136 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 2 | 2006 | 615 | 0.060 |
Why?
|
| Tunica Intima | 1 | 2005 | 59 | 0.060 |
Why?
|
| Animals, Genetically Modified | 1 | 2005 | 63 | 0.060 |
Why?
|
| Calcineurin Inhibitors | 2 | 2005 | 24 | 0.060 |
Why?
|
| Rats, Wistar | 4 | 2008 | 371 | 0.060 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2005 | 48 | 0.060 |
Why?
|
| Potassium Channels, Voltage-Gated | 1 | 2004 | 9 | 0.060 |
Why?
|
| Stem Cells | 1 | 2006 | 248 | 0.060 |
Why?
|
| Rabbits | 4 | 2010 | 509 | 0.060 |
Why?
|
| Blotting, Western | 4 | 2010 | 954 | 0.060 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2004 | 57 | 0.060 |
Why?
|
| Myosin Light Chains | 1 | 2004 | 18 | 0.060 |
Why?
|
| Retrospective Studies | 1 | 2016 | 7277 | 0.060 |
Why?
|
| Green Fluorescent Proteins | 4 | 2011 | 200 | 0.060 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2004 | 63 | 0.060 |
Why?
|
| Stimulation, Chemical | 4 | 2003 | 57 | 0.060 |
Why?
|
| Phosphoproteins | 2 | 2005 | 202 | 0.060 |
Why?
|
| Rats, Inbred F344 | 3 | 2011 | 104 | 0.060 |
Why?
|
| Membrane Proteins | 1 | 2008 | 617 | 0.060 |
Why?
|
| Adrenergic beta-Antagonists | 2 | 1995 | 189 | 0.060 |
Why?
|
| DNA-Binding Proteins | 4 | 2010 | 700 | 0.060 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2005 | 317 | 0.060 |
Why?
|
| Young Adult | 5 | 2013 | 5717 | 0.060 |
Why?
|
| Norepinephrine | 2 | 1996 | 276 | 0.060 |
Why?
|
| Calcium Channels | 1 | 2003 | 59 | 0.050 |
Why?
|
| Genotype | 3 | 2013 | 786 | 0.050 |
Why?
|
| Organ Size | 2 | 2001 | 242 | 0.050 |
Why?
|
| Aequorin | 1 | 2002 | 3 | 0.050 |
Why?
|
| Venae Cavae | 1 | 2003 | 16 | 0.050 |
Why?
|
| Hypertension, Renal | 1 | 2002 | 29 | 0.050 |
Why?
|
| Reproducibility of Results | 2 | 2008 | 2077 | 0.050 |
Why?
|
| Monitoring, Physiologic | 1 | 2004 | 219 | 0.050 |
Why?
|
| Aortic Valve Stenosis | 1 | 2004 | 177 | 0.050 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2002 | 31 | 0.050 |
Why?
|
| Adenosine Triphosphatases | 1 | 2002 | 83 | 0.050 |
Why?
|
| Cardiac Catheterization | 1 | 2005 | 419 | 0.050 |
Why?
|
| Adenosine Triphosphate | 2 | 2005 | 314 | 0.050 |
Why?
|
| Endoribonucleases | 1 | 2002 | 22 | 0.050 |
Why?
|
| Colforsin | 2 | 1992 | 42 | 0.050 |
Why?
|
| Up-Regulation | 1 | 2004 | 682 | 0.050 |
Why?
|
| Enzyme Inhibitors | 1 | 2005 | 659 | 0.050 |
Why?
|
| Cell Size | 2 | 2006 | 76 | 0.050 |
Why?
|
| Cardiac Surgical Procedures | 2 | 2003 | 450 | 0.050 |
Why?
|
| Cyclic AMP | 3 | 1996 | 223 | 0.050 |
Why?
|
| Protein Refolding | 1 | 2021 | 4 | 0.050 |
Why?
|
| Nuclear Proteins | 3 | 2010 | 271 | 0.050 |
Why?
|
| Protein Isoforms | 3 | 2010 | 246 | 0.050 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 2 | 2012 | 51 | 0.050 |
Why?
|
| Cell Line | 3 | 2010 | 1752 | 0.050 |
Why?
|
| Imidazoles | 2 | 2010 | 175 | 0.050 |
Why?
|
| Ubiquitination | 1 | 2021 | 85 | 0.050 |
Why?
|
| Unfolded Protein Response | 1 | 2021 | 70 | 0.050 |
Why?
|
| Gene Frequency | 2 | 2013 | 207 | 0.040 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2001 | 346 | 0.040 |
Why?
|
| Histone Deacetylases | 1 | 2021 | 99 | 0.040 |
Why?
|
| Animals, Newborn | 2 | 2010 | 396 | 0.040 |
Why?
|
| Thrombosis | 1 | 2021 | 218 | 0.040 |
Why?
|
| Dihydropyridines | 1 | 1999 | 13 | 0.040 |
Why?
|
| Cell Death | 2 | 2010 | 329 | 0.040 |
Why?
|
| Benzopyrans | 1 | 1999 | 21 | 0.040 |
Why?
|
| COS Cells | 2 | 2013 | 155 | 0.040 |
Why?
|
| Patch-Clamp Techniques | 2 | 2013 | 204 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 1999 | 82 | 0.040 |
Why?
|
| Pedigree | 1 | 2019 | 159 | 0.040 |
Why?
|
| Autophagy | 1 | 2021 | 208 | 0.040 |
Why?
|
| Neoplasms | 1 | 2010 | 1667 | 0.040 |
Why?
|
| Atherosclerosis | 1 | 2021 | 204 | 0.040 |
Why?
|
| Morphogenesis | 1 | 2019 | 159 | 0.040 |
Why?
|
| Survival Rate | 1 | 2001 | 1056 | 0.040 |
Why?
|
| Risk Factors | 3 | 2019 | 5731 | 0.040 |
Why?
|
| Hypoxia | 1 | 1999 | 169 | 0.040 |
Why?
|
| Prognosis | 2 | 2019 | 2093 | 0.040 |
Why?
|
| Genome-Wide Association Study | 1 | 2019 | 240 | 0.040 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2019 | 194 | 0.040 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2013 | 239 | 0.040 |
Why?
|
| Blood Pressure | 5 | 2006 | 1451 | 0.040 |
Why?
|
| Heart Valves | 1 | 2019 | 171 | 0.040 |
Why?
|
| Dobutamine | 2 | 1999 | 25 | 0.040 |
Why?
|
| Luminescent Proteins | 3 | 2003 | 57 | 0.040 |
Why?
|
| Transfection | 2 | 2013 | 782 | 0.040 |
Why?
|
| Base Sequence | 1 | 2019 | 1015 | 0.040 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 1998 | 116 | 0.040 |
Why?
|
| Oxygen | 1 | 1999 | 386 | 0.040 |
Why?
|
| Inflammation Mediators | 1 | 2019 | 244 | 0.040 |
Why?
|
| Italy | 2 | 2007 | 36 | 0.040 |
Why?
|
| Cerebrovascular Circulation | 1 | 2019 | 296 | 0.040 |
Why?
|
| Child, Preschool | 2 | 2012 | 3187 | 0.040 |
Why?
|
| Oxygen Consumption | 2 | 2008 | 258 | 0.040 |
Why?
|
| Spatio-Temporal Analysis | 1 | 2016 | 28 | 0.040 |
Why?
|
| Cardiotonic Agents | 3 | 2006 | 71 | 0.030 |
Why?
|
| Microscopy, Atomic Force | 1 | 2016 | 66 | 0.030 |
Why?
|
| Rats, Inbred OLETF | 2 | 2006 | 2 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2005 | 331 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2004 | 376 | 0.030 |
Why?
|
| Ion Channel Gating | 2 | 2012 | 42 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2019 | 499 | 0.030 |
Why?
|
| Heart Rate | 2 | 2008 | 568 | 0.030 |
Why?
|
| Bucladesine | 2 | 1992 | 8 | 0.030 |
Why?
|
| Organ Specificity | 2 | 2008 | 167 | 0.030 |
Why?
|
| Extracellular Matrix | 1 | 2019 | 493 | 0.030 |
Why?
|
| Niacinamide | 1 | 1995 | 31 | 0.030 |
Why?
|
| Receptors, Serotonin | 1 | 1995 | 74 | 0.030 |
Why?
|
| Heart Arrest, Induced | 1 | 1995 | 52 | 0.030 |
Why?
|
| RNA-Binding Proteins | 2 | 2011 | 215 | 0.030 |
Why?
|
| Angiotensin II | 1 | 1996 | 220 | 0.030 |
Why?
|
| Cell Separation | 2 | 1996 | 132 | 0.030 |
Why?
|
| NFATC Transcription Factors | 2 | 2005 | 40 | 0.030 |
Why?
|
| Protein Binding | 2 | 2010 | 1027 | 0.030 |
Why?
|
| Random Allocation | 2 | 2006 | 442 | 0.030 |
Why?
|
| Kinetics | 1 | 2016 | 1047 | 0.030 |
Why?
|
| Vasodilator Agents | 1 | 1995 | 138 | 0.030 |
Why?
|
| Child | 3 | 2012 | 6405 | 0.030 |
Why?
|
| Hypertension, Renovascular | 1 | 1994 | 47 | 0.030 |
Why?
|
| Fibrosis | 2 | 2007 | 371 | 0.030 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2013 | 7 | 0.030 |
Why?
|
| Inositol Phosphates | 1 | 1993 | 28 | 0.030 |
Why?
|
| Phosphatidylinositols | 1 | 1993 | 40 | 0.030 |
Why?
|
| Connectin | 2 | 2004 | 14 | 0.030 |
Why?
|
| Myofibrils | 2 | 2004 | 35 | 0.030 |
Why?
|
| Phenylephrine | 1 | 1993 | 61 | 0.030 |
Why?
|
| Ultrasonography | 2 | 2006 | 453 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2008 | 282 | 0.030 |
Why?
|
| Genetic Loci | 1 | 2013 | 59 | 0.030 |
Why?
|
| Hydrolysis | 1 | 1993 | 144 | 0.030 |
Why?
|
| 3' Untranslated Regions | 1 | 2013 | 56 | 0.030 |
Why?
|
| Epinephrine | 1 | 1993 | 103 | 0.030 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2013 | 160 | 0.030 |
Why?
|
| Cyclic GMP | 1 | 2013 | 99 | 0.030 |
Why?
|
| Sodium Chloride, Dietary | 1 | 2013 | 50 | 0.030 |
Why?
|
| Phenotype | 2 | 2010 | 947 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2013 | 103 | 0.030 |
Why?
|
| Propanolamines | 1 | 1993 | 70 | 0.030 |
Why?
|
| Cell Nucleus | 2 | 2010 | 305 | 0.030 |
Why?
|
| DNA, Complementary | 2 | 2005 | 251 | 0.030 |
Why?
|
| Species Specificity | 1 | 1993 | 303 | 0.030 |
Why?
|
| Cardiomegaly, Exercise-Induced | 1 | 2012 | 2 | 0.030 |
Why?
|
| Ranolazine | 1 | 2012 | 2 | 0.030 |
Why?
|
| Consensus Sequence | 1 | 2012 | 20 | 0.030 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2013 | 56 | 0.030 |
Why?
|
| NAV1.5 Voltage-Gated Sodium Channel | 1 | 2012 | 6 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 196 | 0.030 |
Why?
|
| Acetanilides | 1 | 2012 | 9 | 0.030 |
Why?
|
| Adolescent | 3 | 2012 | 8912 | 0.030 |
Why?
|
| Sodium Channel Blockers | 1 | 2012 | 23 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2013 | 179 | 0.030 |
Why?
|
| Papillary Muscles | 1 | 1992 | 30 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2013 | 208 | 0.030 |
Why?
|
| Enzyme Induction | 1 | 2012 | 119 | 0.030 |
Why?
|
| Bromocriptine | 1 | 2012 | 8 | 0.030 |
Why?
|
| Zebrafish | 1 | 2013 | 187 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 2008 | 1664 | 0.030 |
Why?
|
| Protein Interaction Mapping | 1 | 2012 | 62 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2012 | 24 | 0.030 |
Why?
|
| Ligation | 2 | 2002 | 83 | 0.030 |
Why?
|
| Collagen | 2 | 2006 | 636 | 0.020 |
Why?
|
| Polypyrimidine Tract-Binding Protein | 1 | 2011 | 3 | 0.020 |
Why?
|
| SOXD Transcription Factors | 1 | 2011 | 5 | 0.020 |
Why?
|
| Gap Junctions | 1 | 2011 | 29 | 0.020 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2010 | 28 | 0.020 |
Why?
|
| Neovascularization, Physiologic | 1 | 2012 | 164 | 0.020 |
Why?
|
| Piperazines | 1 | 2012 | 206 | 0.020 |
Why?
|
| Electrophysiology | 1 | 1991 | 160 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2012 | 219 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2011 | 147 | 0.020 |
Why?
|
| Mitosis | 1 | 1991 | 76 | 0.020 |
Why?
|
| Trans-Activators | 1 | 2012 | 237 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 2010 | 189 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2012 | 536 | 0.020 |
Why?
|
| Tissue Donors | 1 | 2012 | 195 | 0.020 |
Why?
|
| Cytoplasm | 1 | 2011 | 155 | 0.020 |
Why?
|
| Myosin Heavy Chains | 1 | 2010 | 49 | 0.020 |
Why?
|
| Idoxuridine | 1 | 2010 | 4 | 0.020 |
Why?
|
| Severity of Illness Index | 2 | 2008 | 1851 | 0.020 |
Why?
|
| Cell Fusion | 1 | 2010 | 23 | 0.020 |
Why?
|
| Potassium | 2 | 2004 | 168 | 0.020 |
Why?
|
| Autopsy | 1 | 2010 | 56 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2010 | 237 | 0.020 |
Why?
|
| Polyploidy | 1 | 2010 | 24 | 0.020 |
Why?
|
| Haplotypes | 1 | 2010 | 174 | 0.020 |
Why?
|
| Genetic Markers | 1 | 2010 | 144 | 0.020 |
Why?
|
| Hydrogen Peroxide | 1 | 2010 | 168 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 2010 | 188 | 0.020 |
Why?
|
| Radiation-Sensitizing Agents | 1 | 2010 | 35 | 0.020 |
Why?
|
| Pre-Eclampsia | 1 | 2012 | 202 | 0.020 |
Why?
|
| Cell Division | 1 | 2011 | 541 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2011 | 324 | 0.020 |
Why?
|
| Dopamine | 1 | 1992 | 474 | 0.020 |
Why?
|
| Research | 1 | 1991 | 214 | 0.020 |
Why?
|
| DNA Repair | 1 | 2010 | 127 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2010 | 337 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2011 | 525 | 0.020 |
Why?
|
| Coronary Vessels | 2 | 2002 | 313 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2010 | 489 | 0.020 |
Why?
|
| Regulatory Factor X Transcription Factors | 1 | 2008 | 7 | 0.020 |
Why?
|
| X-Box Binding Protein 1 | 1 | 2008 | 16 | 0.020 |
Why?
|
| Intracellular Space | 1 | 2008 | 42 | 0.020 |
Why?
|
| Ventricular Pressure | 1 | 2008 | 82 | 0.020 |
Why?
|
| Microfilament Proteins | 1 | 2008 | 102 | 0.020 |
Why?
|
| Cell Movement | 1 | 2011 | 630 | 0.020 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2008 | 33 | 0.020 |
Why?
|
| Muscle Cells | 1 | 2008 | 30 | 0.020 |
Why?
|
| Pyridines | 1 | 2010 | 261 | 0.020 |
Why?
|
| Echocardiography, Three-Dimensional | 1 | 2008 | 38 | 0.020 |
Why?
|
| Glyburide | 2 | 1999 | 19 | 0.020 |
Why?
|
| Sheep | 1 | 2008 | 128 | 0.020 |
Why?
|
| Serotyping | 1 | 2007 | 16 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2010 | 331 | 0.020 |
Why?
|
| Observer Variation | 1 | 2008 | 330 | 0.020 |
Why?
|
| Lac Operon | 1 | 2007 | 54 | 0.020 |
Why?
|
| Integrins | 1 | 2007 | 115 | 0.020 |
Why?
|
| Genetic Engineering | 1 | 2007 | 41 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 2008 | 222 | 0.020 |
Why?
|
| Osteoporosis, Postmenopausal | 1 | 2006 | 20 | 0.020 |
Why?
|
| Premenopause | 1 | 2006 | 57 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 2007 | 144 | 0.020 |
Why?
|
| Tibia | 1 | 2007 | 93 | 0.020 |
Why?
|
| Postmenopause | 1 | 2006 | 93 | 0.020 |
Why?
|
| Pregnancy | 1 | 2012 | 2334 | 0.020 |
Why?
|
| Calcium Channels, L-Type | 1 | 2006 | 34 | 0.020 |
Why?
|
| Matrix Metalloproteinases | 1 | 2008 | 223 | 0.020 |
Why?
|
| Bone and Bones | 1 | 2006 | 145 | 0.020 |
Why?
|
| Rats, Long-Evans | 1 | 2006 | 203 | 0.020 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2005 | 18 | 0.020 |
Why?
|
| Genes, Dominant | 1 | 2005 | 51 | 0.020 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2005 | 26 | 0.020 |
Why?
|
| Age Factors | 1 | 2010 | 1864 | 0.020 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2005 | 69 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2006 | 567 | 0.020 |
Why?
|
| Protein Phosphatase 1 | 1 | 2005 | 36 | 0.020 |
Why?
|
| Defective Viruses | 1 | 2004 | 2 | 0.020 |
Why?
|
| Shal Potassium Channels | 1 | 2004 | 4 | 0.020 |
Why?
|
| Ion Transport | 1 | 2004 | 26 | 0.020 |
Why?
|
| Pliability | 1 | 2004 | 8 | 0.020 |
Why?
|
| Carotid Artery Diseases | 1 | 2005 | 83 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2005 | 161 | 0.020 |
Why?
|
| Coronary Artery Disease | 1 | 2010 | 696 | 0.020 |
Why?
|
| Rho Guanine Nucleotide Exchange Factors | 1 | 2004 | 6 | 0.020 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2004 | 19 | 0.020 |
Why?
|
| DNA | 1 | 2007 | 597 | 0.020 |
Why?
|
| Sarcomeres | 2 | 1996 | 32 | 0.020 |
Why?
|
| Sus scrofa | 1 | 2004 | 74 | 0.010 |
Why?
|
| LLC-PK1 Cells | 1 | 2004 | 4 | 0.010 |
Why?
|
| Disease Progression | 1 | 2008 | 1038 | 0.010 |
Why?
|
| Molecular Weight | 1 | 2004 | 358 | 0.010 |
Why?
|
| Pressure | 1 | 2004 | 252 | 0.010 |
Why?
|
| Luciferases | 1 | 2004 | 105 | 0.010 |
Why?
|
| Muscle Relaxation | 1 | 2003 | 31 | 0.010 |
Why?
|
| Sex Factors | 1 | 2007 | 1266 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2006 | 7029 | 0.010 |
Why?
|
| Biomechanical Phenomena | 1 | 2004 | 368 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2005 | 742 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2008 | 1330 | 0.010 |
Why?
|
| Desmin | 1 | 2002 | 13 | 0.010 |
Why?
|
| Compliance | 1 | 2002 | 26 | 0.010 |
Why?
|
| Intraoperative Period | 1 | 2002 | 62 | 0.010 |
Why?
|
| Troponin I | 1 | 2002 | 34 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2006 | 631 | 0.010 |
Why?
|
| Electric Stimulation | 2 | 1994 | 218 | 0.010 |
Why?
|
| Myocardial Revascularization | 1 | 2002 | 56 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2004 | 714 | 0.010 |
Why?
|
| Recovery of Function | 1 | 2005 | 506 | 0.010 |
Why?
|
| Drug Administration Routes | 1 | 2001 | 25 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2002 | 191 | 0.010 |
Why?
|
| A Kinase Anchor Proteins | 1 | 2001 | 7 | 0.010 |
Why?
|
| Glycogen Synthase Kinases | 1 | 2001 | 6 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 9 | 1 | 2001 | 11 | 0.010 |
Why?
|
| Cell Count | 1 | 2001 | 248 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2005 | 848 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2006 | 2358 | 0.010 |
Why?
|
| Coronary Disease | 1 | 2002 | 358 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2004 | 689 | 0.010 |
Why?
|
| Models, Biological | 1 | 2004 | 981 | 0.010 |
Why?
|
| Constriction | 1 | 2000 | 37 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 2005 | 866 | 0.010 |
Why?
|
| Diastole | 1 | 2000 | 161 | 0.010 |
Why?
|
| Isometric Contraction | 1 | 1999 | 33 | 0.010 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 1999 | 140 | 0.010 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2000 | 174 | 0.010 |
Why?
|
| Cardiology | 1 | 2000 | 140 | 0.010 |
Why?
|
| Drug Interactions | 1 | 1999 | 289 | 0.010 |
Why?
|
| Cell Survival | 1 | 2001 | 901 | 0.010 |
Why?
|
| Reaction Time | 1 | 1998 | 170 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2004 | 2007 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2007 | 2324 | 0.010 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 1996 | 28 | 0.010 |
Why?
|
| Myosins | 1 | 1996 | 34 | 0.010 |
Why?
|
| Receptors, Serotonin, 5-HT4 | 1 | 1995 | 1 | 0.010 |
Why?
|
| Receptor Aggregation | 1 | 1995 | 4 | 0.010 |
Why?
|
| Perfusion | 1 | 1996 | 131 | 0.010 |
Why?
|
| Nicorandil | 1 | 1995 | 2 | 0.010 |
Why?
|
| Nitroglycerin | 1 | 1995 | 20 | 0.010 |
Why?
|
| Receptors, Muscarinic | 1 | 1995 | 44 | 0.010 |
Why?
|
| Serotonin Receptor Agonists | 1 | 1995 | 34 | 0.010 |
Why?
|
| Cold Temperature | 1 | 1995 | 90 | 0.010 |
Why?
|
| Serotonin | 1 | 1995 | 144 | 0.010 |
Why?
|
| Membrane Potentials | 1 | 1994 | 200 | 0.010 |
Why?
|
| Biopsy | 1 | 1996 | 540 | 0.010 |
Why?
|
| Indoles | 1 | 1994 | 146 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 1994 | 261 | 0.010 |
Why?
|
| Isotonic Contraction | 1 | 1992 | 4 | 0.010 |
Why?
|
| Diuretics | 1 | 1992 | 97 | 0.010 |
Why?
|
| Body Weight | 1 | 1994 | 554 | 0.010 |
Why?
|
| Ventricular Function, Right | 1 | 1992 | 103 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 1992 | 1046 | 0.010 |
Why?
|